MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in four upcoming investor conferences.
- H.C. Wainwright 24th Annual Global Investment Conference (New York, NY)
Presentation on Monday, September 12th at 11.30 AM ET
- Morgan Stanley 20th Annual Global Healthcare Conference (New York, NY)
Fireside chat on Wednesday, September 14th at 8:35 AM ET
- Capital One Spatial Biology & Proteomics Summit (Virtual)
Spatial Biology & Single Cell panel discussion on Wednesday, September 28th at 10:15 AM ET
Executive panel discussion on Wednesday, September 28th at 1:00 PM ET
- Bank of America Healthcare Innovation Forum (Virtual)
Spatial Biology & Single Cell panel discussion on Thursday, September 29th at 11 AM ET
A live and archived webcast of the Morgan Stanley Global Healthcare Conference will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com
Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com
